Wegovy (semaglutide) is approved by the U.S. Food and Drug Administration (FDA) for weight loss and weight management in ...

Dr. Reddy's had announced that it has signed a collaboration agreement with Alvotech to co-develop the biosimilar candidate ...

Denmark-based multinational pharmaceutical company Novo Nordisk will be making available in the Philippines within this year ...

A GROWING number of slimmers are trying to squeeze extra jabs out of empty Mounjaro pens in a risky bid to cut costs. The ...

Ozempic-maker Novo Nordisk on Friday ousted its CEO Lars Fruergaard Jorgensen over concerns the company is losing its first-mover advantage in the competitive obesity drug market to American rival Eli ...

We have five products that will launch in the next 12-18 months. We recently launched Yesintek in the immunology space -- a ...

A MUM has revealed she has no regrets about spending £1,200 on confidence-boosting Mounjaro – despite being in £21,000 of ...

Novo Nordisk NVO and Viking Therapeutics VKTX have emerged as notable players in the obesity space. A market leader in the GLP-1 space, Novo Nordisk markets its semaglutide drugs under brand names ...

Eli Lilly's weight-loss and diabetes drug Mounjaro, has seen sales in India jump 60 per cent between April and May. The ...

Women taking weight-loss jabs are being warned they must use effective contraception as some women report surprise ‘Ozempic ...

Eli Lilly and Camurus have entered into partnership worth up to $870m to develop long-acting therapies in cardiometabolic ...